Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting
H Ahmed, AM Hammad, AI Abushouk, M Zidan… - Current problems in …, 2018 - Elsevier
Although chemotherapeutic agents represent a cornerstone of cancer treatment,
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …
Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting
H Ahmed, AM Hammad… - Current problems …, 2018 - pubmed.ncbi.nlm.nih.gov
Although chemotherapeutic agents represent a cornerstone of cancer treatment,
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …
Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting
H Ahmed, AM Hammad, AI Abushouk, M Zidan… - Current Problems in …, 2018 - infona.pl
Although chemotherapeutic agents represent a cornerstone of cancer treatment,
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …
Meta-analysis of safety and efficacy of rolapitant, NK-1 receptor antagonist for prevention of chemotherapy-induced nausea and vomiting.
H Ahmed, AM Hammad, AI Abushouk… - Current Problems in …, 2017 - europepmc.org
Although chemotherapeutic agents represent a cornerstone of cancer treatment,
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …
chemotherapy-induced nausea and vomiting (CINV) affect the patients' quality of life and …